Estimating Trends in the Proportion of Transmitted and Acquired HIV Drug Resistance in a Long Term Observational Cohort in Germany

First Line Treatment Response in Patients with Transmitted HIV Drug Resistance and Well Defined Time Point of HIV Infection: Updated Results from the German HIV-1 Seroconverter Study

(2014) Fabia zu Knyphausen et al.   PLoS One

Declining Prevalence of HIV-1 Drug Resistance in Antiretroviral Treatment-exposed Individuals in Western Europe

(2013) A. De Luca et al.   JOURNAL OF INFECTIOUS DISEASES

Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

(2012) Gilberto Betancor et al.   Retrovirology

Spillover adherence effects of fixed-dose combination HIV therapy

(2012) Teresa Kauf et al.   Patient Preference and Adherence

Clinical implications of fixed-dose coformulations of antiretrovirals on the outcome of HIV-1 therapy

(2011) Josep M. Llibre et al.   AIDS

Cohort profile: the German ClinSurv HIV project - a multicentre open clinical cohort study supplementing national HIV surveillance

(2010) J Bätzing-Feigenbaum et al.   HIV MEDICINE

Prevalence of Transmitted Drug Resistance and Impact of Transmitted Resistance on Treatment Success in the German HIV-1 Seroconverter Cohort

(2010) Barbara Bartmeyer et al.   PLoS One

Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update

(2009) Diane E. Bennett et al.   PLoS One

Transmission networks of drug resistance acquired in primary/early stage HIV infection

(2008) Bluma G Brenner et al.   AIDS

Inferior Clinical Outcome of the CD4+Cell Count–Guided Antiretroviral Treatment Interruption Strategy in the SMART Study: Role of CD4+Cell Counts and HIV RNA Levels during Follow‐up

(2008)   JOURNAL OF INFECTIOUS DISEASES